These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Infantile hemangioma : Clinical manifestation, treatment, and differential diagnoses]. Höger PH; Hamm H Dermatologie (Heidelb); 2023 May; 74(5):331-339. PubMed ID: 37083897 [TBL] [Abstract][Full Text] [Related]
29. Is Routine Electrocardiography Necessary Before Initiation of Propranolol for Treatment of Infantile Hemangiomas? Yarbrough KB; Tollefson MM; Krol AL; Leitenberger SL; Mann JA; MacArthur CJ Pediatr Dermatol; 2016 Nov; 33(6):615-620. PubMed ID: 27599450 [TBL] [Abstract][Full Text] [Related]
30. Medical Management of Infantile Hemangiomas: An Update. Colmant C; Powell J Paediatr Drugs; 2022 Jan; 24(1):29-43. PubMed ID: 34677814 [TBL] [Abstract][Full Text] [Related]
31. Propranolol is more effective than pulsed dye laser and cryosurgery for infantile hemangiomas. Kagami S; Kuwano Y; Shibata S; Uwajima Y; Yamada D; Miyamoto A; Miyagawa T; Araki M; Takahashi K; Isomura S; Aozasa N; Masui Y; Yamamoto M; Inuzuka R; Katori T; Sato S Eur J Pediatr; 2013 Nov; 172(11):1521-6. PubMed ID: 23812512 [TBL] [Abstract][Full Text] [Related]
32. Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches. Craiglow BG; Antaya RJ Paediatr Drugs; 2013 Apr; 15(2):133-8. PubMed ID: 23456550 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of cases with infantile hemangioma requiring treatment. Maraşli H; Acipayam C; Güllü UU; Dinçer S; Dalgiç EF; Karaküçük SN; Yurttutan S Folia Med (Plovdiv); 2022 Feb; 64(1):67-74. PubMed ID: 35851882 [TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial. Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828 [TBL] [Abstract][Full Text] [Related]
35. Propranolol treatment in life-threatening airway hemangiomas: a case series and review of literature. Broeks IJ; Hermans DJ; Dassel AC; van der Vleuten CJ; van Beynum IM Int J Pediatr Otorhinolaryngol; 2013 Nov; 77(11):1791-800. PubMed ID: 24074695 [TBL] [Abstract][Full Text] [Related]
36. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study. Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954 [TBL] [Abstract][Full Text] [Related]
37. Retrospective Study of Nasal Infantile Hemangiomas: Characteristics, Complications, and Outcomes. Kryatova MS; Rainer BM; Zhao J; Villarroel VA; Yasmine Kirkorian A; Grossberg AL; Puttgen KB; Cohen BA Pediatr Dermatol; 2016 Nov; 33(6):652-658. PubMed ID: 27699864 [TBL] [Abstract][Full Text] [Related]
38. Skin sequelae in patients with infantile hemangioma: a systematic review. Li W; Kang J; Bai S; Yuan L; Liu J; Bi Y; Sun J; He Y Eur J Pediatr; 2023 Feb; 182(2):479-488. PubMed ID: 36434402 [TBL] [Abstract][Full Text] [Related]
39. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature. Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522 [TBL] [Abstract][Full Text] [Related]
40. Infantile hemangiomas: an update on pathogenesis and therapy. Chen TS; Eichenfield LF; Friedlander SF Pediatrics; 2013 Jan; 131(1):99-108. PubMed ID: 23266916 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]